Company Filing History:
Years Active: 2016
Title: Emilio Gonzalez: Innovator in Molecular Probes for Cancer Diagnosis
Introduction
Emilio Gonzalez is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of molecular diagnostics, particularly in the development of innovative probes for cancer detection and treatment. His work focuses on enhancing the specificity and effectiveness of diagnostic tools used in medical applications.
Latest Patents
Emilio Gonzalez holds a patent for "Self-quenching activatable COX-2-specific multi-modal molecular probes for diagnosis of cancers, inflammation, and immune system disorders." This patent encompasses pharmaceutically acceptable compositions formulated for the topical or transdermal delivery of probes specific for cyclooxygenase-2 (COX-2) in both human and non-human subjects. The activatable probe features a fluorescent moiety that includes a fluorophore attached to a compound with selective affinity for COX-2, along with a removable fluorescence quencher linked by a cleavable linker. Upon delivery, the probe is localized in tissues with elevated COX-2 levels, and the linker is cleaved to release the quencher, allowing for detectable fluorescent emission upon irradiation.
Career Highlights
Emilio Gonzalez is affiliated with Leland Stanford Junior University, where he continues to advance his research in molecular diagnostics. His innovative approach to developing COX-2-specific probes has the potential to significantly improve cancer diagnosis and treatment strategies.
Collaborations
Emilio has collaborated with notable researchers such as Jayakumar Rajadas and Hyejun Ra, contributing to the advancement of his work in molecular probes and diagnostics.
Conclusion
Emilio Gonzalez is a key figure in the field of molecular diagnostics, with a focus on developing innovative tools for cancer detection. His contributions are paving the way for more effective diagnostic methods in the medical field.